Erythropoietin enhances hydrogen peroxide-mediated dilatation of canine coronary collateral arterioles during myocardial ischemia in dogs in vivo

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 6, 2010, Pages

  Yada, Toyotaka ^a   Shimokawa, Hiroaki ^b   Hiramatsu, Osamu ^a   Satoh, Minoru ^a   Kashihara, Naoki ^a   Takaki, Aya ^b   Goto, Masami ^a   Ogasawara, Yasuo ^a   Kajiya, Fumihiko ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary microcirculation; Endothelium derived hyperpolarizing factors

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; APAMIN; CALCIUM ION; CATALASE; CHARYBDOTOXIN; ERYTHROPOIETIN; HYDROGEN PEROXIDE; IBERIOTOXIN; N(G) METHYLARGININE; PROTEIN KINASE B; TROPONIN T; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DILATATION; DOG; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VASODILATATION;

ANIMALS; ANTIOXIDANTS; ARTERIOLES; CARBON DIOXIDE; COLLATERAL CIRCULATION; CORONARY CIRCULATION; CORONARY VESSELS; DEOXYGUANOSINE; DISEASE MODELS, ANIMAL; DOGS; ENZYME INHIBITORS; ERYTHROPOIETIN; FEMALE; HYDROGEN PEROXIDE; MALE; MYOCARDIAL ISCHEMIA; NITRIC OXIDE SYNTHASE TYPE III; OXYGEN; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; POTASSIUM CHANNEL BLOCKERS; PROTEIN KINASE INHIBITORS; TROPONIN T; VASODILATION; VASODILATOR AGENTS;

EID: 78649758696     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00331.2010     Document Type: Article

References (51)

1. Alioglu E, Ercan E, Sonmez Tamer G, Duman C, Turk U, Tengiz I, Tuzun N, Saygi S. Decreased circulatory erythropoietin in hyperacute phase of myocardial ischemia. Int J Cardiol. In press.
2. Bauersachs J, Hecker M, Busse R. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol 113: 1548-1553, 1994.
3. Cai Z, Semenza GL. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/ reperfusion injury. Circulation 109: 2050-2053, 2004.
4. Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A, Brines M. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 100: 4802-4806, 2003.
5. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as an endothelium-derived hyperpolarizing factor. Circ Res 78: 415-423, 1996.
6. 2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation. Biochem Biophys Res Commun 303: 1152-1158, 2003.
7. Chong ZZ, Kang JQ, Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106: 2973-2979, 2002.
8. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396: 269-272, 1998. (Pubitemid 28541391)
9. Griffin KL, Woodman CR, Price EM, Laughlin MH, Parker JL. Endothelium-mediated relaxation of porcine collateral-dependent arterioles is improved by exercise training. Circulation 104: 1393-1398, 2001.
10. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 73: 411-418, 2009.
11. Hirata A, Minamino T, Asanuma H, Fujita M, Wakeno M, Myoishi M, Tsukamoto O, Okada K, Koyama H, Komamura K, Takashima S, Shinozaki Y, Mori H, Shiraga M, Kitakaze M, Hori M. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J Am Coll Cardiol 48: 176-184, 2006.
12. Kasai H. A new automated method to analyze urinary 8- hydroxydeoxyguanosine by a high-performance liquid chromatography- electrochemical detector system. J Radiat Res (Tokyo) 44: 185-189, 2003.
13. Lamping KG, Bloom EN, Harrison DG. Regulation of native collateral vessel dilation after coronary occlusion in the dog. Am J Physiol Heart Circ Physiol 266: H769-H778, 1994.
14. Li Y, Takemura G, Okada H, Miyata S, Maruyama R, Li L, Higuchi M, Minatoguchi S, Fujiwara T, Fujiwara H. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res 71: 684-694, 2006.
15. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106: 1521-1530, 2000.
16. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 290: 909-913, 2002.
17. Mihov D, Bogdanov N, Grenacher B, Gassmann M, Zünd G, Bogdanova A, Tavakoli R. Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production. Eur J Cardiothorac Surg 35: 839-846, 2009.
18. + channels. Circ Res 83: 501-507, 1998.
19. + channels. Circulation 103:1992-1998, 2001.
20. Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, Gutterman DD. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 92: e31-e40, 2003.
21. Morikawa K, Shimokawa H, Matoba T, Kubota H, Akaike T, Talukder MA, Hatanaka M, Fujiki T, Maeda H, Takahashi S, Takeshita A. Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarization. J Clin Invest 112: 1871-1879, 2003.
22. Morikawa K, Fujiki T, Matoba T, Kubota H, Hatanaka M, Takahashi S, Shimokawa H. Important role of superoxide dismutase in EDHF-mediated responses of human mesenteric arteries. J Cardiovasc Pharmacol 44:552-556, 2004.
23. + channels regulates coronary blood flow in ischemic myocardium. Circulation 95:1560-1567, 1997.
24. Ozawa T, Toba K, Suzuki H, Kato K, Iso Y, Akutsu Y, Kobayashi Y, Takeyama Y, Kobayashi N, Yoshimura N, Akazawa K, Aizawa Y; EPO/AMI-1 Pilot Study Researchers. Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO/AMI-1 study. Circ J 74: 1415-1423, 2010.
25. Park Y, Capobianco S, Gao X, Falck JR, Dellsperger KC, Zhang C. Role of EDHF in type 2 diabetes-induced endothelial dysfunction. Am J Physiol Heart Circ Physiol 295: H1982-H1988, 2008.
26. Parsa CJ, Matsumoto A, Kim J, Riel RU, Pascal LS, Walton GB, Thompson RB, Petrofski JA, Annex BH, Stamler JS, Koch WJ. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 112: 999-1007, 2003.
27. Rui T, Feng Q, Ming L, Peng T, Zhang J, Xu M, Abeld ED, Xenocostase A, Kvietysa PR. Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1. Cardiovasc Res 65: 719-727, 2005.
28. Santhanam AV, Smith LA, Nath KA, Katusic ZS. In vivo stimulatory effect of erythropoietin on endothelial nitric oxide synthase in cerebral arteries. Am J Physiol Heart Circ Physiol 291: H781-H786, 2006.
29. Satoh M, Fujimoto S, Arakawa S, Yada T, Namikoshi T, Haruna Y, Horike H, Sasaki T, Kashihara N. Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy. Nephrol Dial Transplant 23: 3806-3813, 2008.
30. Sellke FW, Kagaya Y, Johnson RG, Shafique T, Schoen FJ, Grossman W, Weintraub RM. Endothelial modulation of porcine coronary micro-circulation perfused via immature collaterals. Am J Physiol Heart Circ Physiol 262: H1669-H1675, 1992.
31. Shafi NI, Andresen J, Marrelli SP, Bryan RM Jr. Erythropoietin potentiates EDHF-mediated dilations in rat middle cerebral arteries. J Neurotrauma 25: 257-265, 2008.
32. Shi Y, Rafiee P, Su J, Pritchard KA Jr, Tweddell JS, Baker JE. Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels. Basic Res Cardiol 99: 173-182, 2004.
33. Siegel G, Emden J, Wenzel K, Mironneau J, Stock G. Potassium channel activation in vascular smooth muscle. Adv Exp Med Biol 311: 53-72, 1992.
34. Steenbergen C, Murphy E, Levy L, London RE. Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res 60: 700-707, 1987.
35. Tada H, Kagaya Y, Takeda M, Ohta J, Asaumi Y, Satoh K, Ito K, Karibe A, Shirato K, Minegishi N, Shimokawa H. Endogenous erythro-poietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion. Cardiovasc Res 71: 408-410, 2006.
36. Takaki A, Morikawa K, Murayama Y, Yamagishi H, Hosoya M, Ohashi J, Shimokawa H. Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice. J Cardiovasc Pharmacol 52: 510-517, 2008.
37. Takaki A, Morikawa K, Tsutsui M, Murayama Y, Tekes E, Yamagishi H, Ohashi J, Yada T, Yanagihara N, Shimokawa H. Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice. J Exp Med 205: 2053-2063, 2008.
38. Taylor HJ, Chaytor AT, Evance WH, Griffith TM. Inhibition of the gap junctional component of endothelium-dependent relaxations in rabbit iliac artery by 18-alpha glycyrrhetinic acid. Br J Pharmacol 125: 1-3, 1998.
39. Thengchaisri N, Shipley R, Ren Y, Parker J, Kuo L. Exercise training restores coronary arteriolar dilation to NOS activation distal to coronary artery occlusion: role of hydrogen peroxide. Arterioscler Thromb Vasc Biol 27: 791-798, 2007.
40. Thomas SR, Chen K, Keaney JF Jr. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem 277: 6017-6024, 2002.
41. Tramontano AF, Muniyappa R, Black AD, Blendea MC, Cohen I, Deng L, Sowers JR, Cutaia MV, El-Sherif N. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun 308: 990-994, 2003.
42. van der Meer P, Lipsic E, Henning RH, Boddeus K, van der Velden J, Voors AA, van Veldhuisen DJ, van Gilst WH, Schoemaker RG. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J Am Coll Cardiol 46: 125-133, 2005.
43. Vanhoutte PM. Endothelial dysfunction. Circ J 73: 595-601, 2009.
44. Wright GL, Hanlon P, Amin K, Steenbergen C, Murphy E, Arcasoy MO. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. FASEB J 18: 1031-1033, 2004.
45. Wysocki H, Kazmierczak M, Wykretowicz A. Peroxide plasma level in patients with coronary heart disease as a possible indicator of ischemia during exercise test. Coron Artery Dis 4: 645-647, 1993.
46. + channels in the cardiac inner mitochondrial membrane. Science 298: 1029-1033, 2002.
47. Yada T, Hiramatsu O, Kimura A, Goto M, Ogasawara Y, Tsujioka K, Yamamori S, Ohno K, Hosaka H, Kajiya F. In vivo observation of subendocardial microvessels of the beating porcine heart using a needle-probe videomicroscope with a CCD camera. Circ Res 72: 939-946, 1993.
48. Yada T, Shimokawa H, Hiramatsu O, Kajita T, Shigeto F, Goto M, Ogasawara Y, Kajiya F. Hydrogen peroxide, an endogenous endothelium- derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo. Circulation 107: 1040-1045, 2003.
49. Yada T, Shimokawa H, Hiramatsu O, Haruna Y, Morita Y, Kashihara N, Shinozaki Y, Mori H, Goto M, Ogasawara Y, Kajiya F. Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation in vivo. Am J Physiol Heart Circ Physiol 291: H1138-H1146, 2006. (Pubitemid 44343657)
50. Yada T, Shimokawa H, Hiramatsu O, Shinozaki Y, Mori H, Goto M, Ogasawara Y, Kajiya F. Important role of endogenous hydrogen peroxide in pacing-induced metabolic coronary vasodilation in dogs in vivo. J Am Coll Cardiol 50:1272-1278, 2007.
51. Yada T, Shimokawa H, Morikawa K, Takaki A, Shinozaki Y, Mori H, Goto M, Ogasawara Y, Kajiya F. Role of Cu,Zn-SOD in the synthesis of endogenous vasodilator hydrogen peroxide during reactive hyperemia in mouse mesenteric microcirculation in vivo. Am J Physiol Heart Circ Physiol 294: H441-H448, 2008.